PharVision Advisers’s Saic SAIC Stock Holding History

PharVision Advisers’s Portfolio SAIC Stock Details SAIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,200	Closed	-$360K	–	776
2025 Q2	$360K	Buy	+3,200	New	+$365K	0.52%	37

Other funds holding SAIC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PharVision Advisers's SAIC Position: Q3 2025 in Review

PharVision Advisers sold out of Saic (SAIC) in Q3 2025, closing a stake of 3,200 shares — an estimated $360K sold.

PharVision Advisers first reported a position in SAIC in Q2 2025 and held it in 1 quarter. The position peaked at $360K in Q2 2025. 410 funds tracked by Wall St. Rank hold SAIC as of Q3 2025.

PharVision Advisers reported no remaining Saic position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 3,200 Saic shares in Q3 2025, an estimated $360K.
PharVision Advisers first reported a position in Saic in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Saic position peaked at $360K in Q2 2025.
410 funds tracked by Wall St. Rank held Saic as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.